Informatie:
Fout:
ID
19965
Beschrijving
Supplemental Benefit of Angiotensin Receptor Blocker in Hypertensive Patients With Stable Heart Failure Using Olmesartan; ODM derived from: https://clinicaltrials.gov/show/NCT00417222
Link
https://clinicaltrials.gov/show/NCT00417222
Trefwoorden
Versies (1)
- 01-02-17 01-02-17 -
Geüploaded op
1 februari 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Chronic Heart Failure NCT00417222
Eligibility Chronic Heart Failure NCT00417222
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Heart Failure NCT00417222
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
criteria Fulfill
Item
patients who meet all of the following criteria.
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Chronic heart failure New York Heart Association Classification
Item
patients with nyha class ii through iv chronic heart failure.
boolean
C0264716 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,2])
Hypertensive disease | Antihypertensive Agents
Item
patients who have a history of hypertension or those who have antihypertensive medications.
boolean
C0020538 (UMLS CUI [1])
C0003364 (UMLS CUI [2])
C0003364 (UMLS CUI [2])
Age
Item
patients who are aged 20 years or older and less than 80 years at the entry.
boolean
C0001779 (UMLS CUI [1])
Angiotensin-Converting Enzyme Inhibitors | Adrenergic beta-Antagonists
Item
stable patients who have angiotensin converting enzyme inhibitor and/or beta-blocker.
boolean
C0003015 (UMLS CUI [1])
C0001645 (UMLS CUI [2])
C0001645 (UMLS CUI [2])
Angiotensin II receptor antagonist Absent
Item
patients who do not have angiotensin ii receptor blocker.
boolean
C0521942 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
Renal dysfunction | Creatinine measurement, serum | Chronic haemodialysis
Item
patients who have renal dysfunction (serum creatinine >=3.0mg/dl) or those who are receiving chronic hemodialysis.
boolean
C3279454 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C1740835 (UMLS CUI [3])
C0201976 (UMLS CUI [2])
C1740835 (UMLS CUI [3])
Hypersensitivity olmesartan
Item
history of drug hypersensitivity to olmesartan.
boolean
C0020517 (UMLS CUI [1,1])
C1098320 (UMLS CUI [1,2])
C1098320 (UMLS CUI [1,2])
Liver Dysfunction Severe
Item
patients who have severe liver dysfunction.
boolean
C0086565 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Angioedema
Item
history of angioedema.
boolean
C0002994 (UMLS CUI [1])
Malignant Neoplasms | Life threatening illness Prognosis bad
Item
history of malignant tumor or life-threatening illness of poor prognosis.
boolean
C0006826 (UMLS CUI [1])
C3846017 (UMLS CUI [2,1])
C0278252 (UMLS CUI [2,2])
C3846017 (UMLS CUI [2,1])
C0278252 (UMLS CUI [2,2])
Pregnancy | Possible pregnancy
Item
pregnant or possibly pregnant patients.
boolean
C0032961 (UMLS CUI [1])
C0425965 (UMLS CUI [2])
C0425965 (UMLS CUI [2])
Cardiovascular Surgical Procedure
Item
cardiovascular surgery within 6months prior to the date of the entry.
boolean
C0038897 (UMLS CUI [1])
Myocardial Infarction
Item
acute myocardial infarction within 6 months prior to the date of the entry.
boolean
C0027051 (UMLS CUI [1])
Percutaneous Coronary Intervention | Stenting
Item
percutaneous coronary intervention or stent implantation within 6 months prior to the date of the entry.
boolean
C1532338 (UMLS CUI [1])
C2348535 (UMLS CUI [2])
C2348535 (UMLS CUI [2])
Study Subject Participation Status Inappropriate
Item
other patients deemed unsuitable as subjects of the study by the treating physician.
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,2])